Active substances
Hydrochlorothiazide + Olmesartan
- SFDA 22
- US FDA 17
- Health Canada 21
- US price lines 4
- NHS prices 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CO-OLMEPRESS 20 mg/12.5 mg F.C. Tablet | 20,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 48.80 | Generic · Prescription | LABORATORIOS CINFA SA | Valid |
| CO-OLMEPRESS 40 mg/12.5 mg F.C. Tablet | 40,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 66.15 | Generic · Prescription | LABORATORIOS CINFA SA | Valid |
| CO-OLMEPRESS 40 mg/25 mg F.C. Tablet | 40,25 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 66.15 | Generic · Prescription | LABORATORIOS CINFA SA | Valid |
| Erastapecs Plus 20/12.5MG F.C.TABLET | 20,12.5 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 47.95 | Generic · Prescription | Apex Pharma | Valid |
| Erastapecs Plus 40/12.5MG F.C.TABLET | 40,12.5 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 63.80 | Generic · Prescription | Apex Pharma | Valid |
| NORMATEC PLUS 20/12.5 mg film-coated tablet | 20,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 59.20 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| NORMATEC PLUS 40/12.5 mg film-coated tablet | 40,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 78.80 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| NORMATEC PLUS 40/25 mg film-coated tablet | 40,25 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 78.80 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| OLMAZIDE 20/12.5MG F.C.TABLET | 20,12.5 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 47.95 | Generic · Prescription | Saudi Amarox | Valid |
| OLMAZIDE 40/12.5MG | 40,12.5 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 63.80 | Generic · Prescription | Saudi Amarox | Valid |
| OLMAZIDE 40/25MG | 40,25 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 63.80 | Generic · Prescription | Saudi Amarox | Valid |
| OLMETEC PLUS 20MG-12.5MG F.C. TABLETS | 20,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 65.60 | NCE · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Valid |
| OLMETEC PLUS 40MG-12.5MG F.C. TABLETS | 40,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 87.30 | NCE · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Valid |
| OLMETEC PLUS 40MG-25MG F.C. TABLETS | 40,25 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 87.30 | NCE · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Valid |
| Olcontro HCT | 20,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 33.55 | Generic · Prescription | Med City Pharma | Valid |
| Olcontro HCT | 40,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 44.65 | Generic · Prescription | Med City Pharma | Valid |
| Olmetrol Plus | 40,12.5 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 63.80 | Generic · Prescription | RIYADH PHARMA | Valid |
| Olmetrol Plus | 20,12.50 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 47.95 | Generic · Prescription | RIYADH PHARMA | Valid |
| Olmetrol Plus | 40,25 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 63.80 | Generic · Prescription | RIYADH PHARMA | Valid |
| Olsar Plus | 40,25 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 70.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| Olsar Plus | 40,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 70.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| Olsar Plus | 20,12.5 mg,mg | Film-coated tablet · Oral use | 28 Blister | SAR 53.30 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
Indications — CHI Daman Drug Formulary
HYPERTENSION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| BENICAR HCT | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | COSETTE | Prescription | 5 Jun 2003 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | ALEMBIC | Prescription | 24 Apr 2017 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | AUROBINDO PHARMA | Prescription | 24 Apr 2017 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | PRINSTON INC | Prescription | 24 Apr 2017 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | ACCORD HLTHCARE | Prescription | 7 Feb 2019 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 25MG;40MG; 12.5MG;40MG | tablet · oral | PHARMAZONE | Prescription | 17 Sep 2019 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | MACLEODS PHARMS | Prescription | 1 Jun 2023 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | ALKEM LABS LTD | Prescription | 11 Jul 2024 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | HETERO LABS LTD V | Prescription | 25 Jul 2025 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | HANGZHOU BINJIANG | Prescription | 20 Aug 2025 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | MSN | Prescription | 26 Sep 2025 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | SCIEGEN PHARMS | Prescription | 31 Mar 2026 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | MICRO LABS | Prescription | 13 Apr 2026 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | NATCO PHARMA USA | Discontinued | 26 Oct 2016 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | TEVA PHARMS USA | Discontinued | 24 Apr 2017 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | TORRENT | Discontinued | 3 May 2017 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 12.5MG;20MG; 12.5MG;40MG; 25MG;40MG | tablet · oral | ZYDUS PHARMS | Discontinued | 24 Feb 2023 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACH-OLMESARTAN HCTZ | 02468948 | 20 MG; 12.5 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| ACH-OLMESARTAN HCTZ | 02468956 | 40 MG; 12.5 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| ACH-OLMESARTAN HCTZ | 02468964 | 40 MG; 25 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| AURO-OLMESARTAN HCTZ | 02476487 | 20 MG; 12.5 MG | TABLET · ORAL | AURO PHARMA INC |
| AURO-OLMESARTAN HCTZ | 02476495 | 12.5 MG; 40 MG | TABLET · ORAL | AURO PHARMA INC |
| AURO-OLMESARTAN HCTZ | 02476509 | 25 MG; 40 MG | TABLET · ORAL | AURO PHARMA INC |
| GLN-OLMESARTAN HCTZ | 02475707 | 12.5 MG; 20 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| GLN-OLMESARTAN HCTZ | 02475715 | 12.5 MG; 40 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| GLN-OLMESARTAN HCTZ | 02475723 | 25 MG; 40 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| NRA-OLMESARTAN HCTZ | 02508273 | 12.5 MG; 20 MG | TABLET · ORAL | NORA PHARMA INC |
| NRA-OLMESARTAN HCTZ | 02508281 | 12.5 MG; 40 MG | TABLET · ORAL | NORA PHARMA INC |
| NRA-OLMESARTAN HCTZ | 02508303 | 40 MG; 25 MG | TABLET · ORAL | NORA PHARMA INC |
| OLMESARTAN/HCTZ | 02509601 | 12.5 MG; 20 MG | TABLET · ORAL | SANIS HEALTH INC |
| OLMESARTAN/HCTZ | 02509628 | 40 MG; 25 MG | TABLET · ORAL | SANIS HEALTH INC |
| OLMESARTAN/HCTZ | 02509636 | 12.5 MG; 40 MG | TABLET · ORAL | SANIS HEALTH INC |
| OLMETEC PLUS | 02319616 | 12.5 MG; 20 MG | TABLET · ORAL | ORGANON CANADA INC. |
| OLMETEC PLUS | 02319624 | 12.5 MG; 40 MG | TABLET · ORAL | ORGANON CANADA INC. |
| OLMETEC PLUS | 02319632 | 40 MG; 25 MG | TABLET · ORAL | ORGANON CANADA INC. |
| TEVA-OLMESARTAN / HCTZ | 02443112 | 12.5 MG; 20 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-OLMESARTAN / HCTZ | 02443120 | 40 MG; 12.5 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-OLMESARTAN / HCTZ | 02443139 | 40 MG; 25 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BENICAR HCT 40-12.5 MG TABLET | $17.20133 | per EA | 1 Jul 2026 |
| US NADAC | OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | $0.16502 | per EA | 23 Sep 2026 |
| US NADAC | OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB | $0.21959 | per EA | 23 Sep 2026 |
| US NADAC | OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB | $0.20907 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets | £12.95 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Olmesartan medoxomil 20mg / Hydrochlorothiazide 25mg tablets | £12.95 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Olmesartan medoxomil 40mg / Hydrochlorothiazide 12.5mg tablets | £17.50 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.